Patricia Troncoso
Papers
3
Total Citations
56
H-Index
3
About
Patricia Troncoso is a leading urological pathologist whose work has fundamentally advanced the understanding and management of prostate cancer. Her research centers on refining pathological staging, improving the accuracy of Gleason scoring, and exploring neoadjuvant therapies to optimize surgical outcomes. A key contribution is her landmark study on surgeon-led lymph node staging during robot-assisted radical prostatectomy, which systematically evaluated pathological outcomes based on dissection templates and patient selection—a work cited over 30 times that has helped standardize surgical approaches. She also made a major impact with her investigation into biopsy Gleason score upgrading or downgrading at radical prostatectomy, demonstrating how routine clinical features can predict this “regression to the mean” and correlating these changes with biochemical relapse rates (23 citations). More recently, she has been at the forefront of a phase II study examining six months of apalutamide prior to radical prostatectomy in intermediate-risk patients, aiming to reduce pathologic features that drive post-operative radiation therapy. Through these contributions, Troncoso has provided clinicians with critical tools for risk stratification and treatment planning, directly improving patient outcomes in prostate cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3